959 related articles for article (PubMed ID: 18022596)
1. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
2. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex.
Ajayi AA; Fidelis P
J Cardiovasc Pharmacol; 2006 Nov; 48(5):191-8. PubMed ID: 17110800
[TBL] [Abstract][Full Text] [Related]
3. [Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
Wang LH; Duan HJ; Shi YH; Liu QJ; He N; Liu SX
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):734-7. PubMed ID: 15585148
[TBL] [Abstract][Full Text] [Related]
4. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
Vallon V; Albinus M; Blach D
J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.
Wang J; Huang H; Liu P; Tang F; Qin J; Huang W; Chen F; Guo F; Liu W; Yang B
Eur J Pharmacol; 2006 Dec; 553(1-3):297-303. PubMed ID: 17074319
[TBL] [Abstract][Full Text] [Related]
7. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
Hill JV; Findon G; Appelhoff RJ; Endre ZH
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
[TBL] [Abstract][Full Text] [Related]
8. Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.
Riad A; Unger D; Du J; Westermann D; Mohr Z; Sobirey M; Dorenkamp M; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2007 Jan; 554(1):40-5. PubMed ID: 17097634
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
10. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
[TBL] [Abstract][Full Text] [Related]
11. p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 2. Improved renal function as assessed by dynamic contrast-enhanced magnetic resonance imaging.
Lenhard SC; Nerurkar SS; Schaeffer TR; Mirabile RC; Boyce RW; Adams DF; Jucker BM; Willette RN
J Pharmacol Exp Ther; 2003 Dec; 307(3):939-46. PubMed ID: 14561850
[TBL] [Abstract][Full Text] [Related]
12. Effects of cyclooxygenase-2 (COX-2) inhibition on plasma and renal renin in diabetes.
Komers R; Tian W; Lindsley JN; Oyama TT; Cohen DM; Anderson S
J Lab Clin Med; 2002 Nov; 140(5):351-7. PubMed ID: 12434137
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of protein kinase Cbeta protects against diabetes-induced impairment in arachidonic acid dilation of small coronary arteries.
Zhou W; Wang XL; Lamping KG; Lee HC
J Pharmacol Exp Ther; 2006 Oct; 319(1):199-207. PubMed ID: 16861398
[TBL] [Abstract][Full Text] [Related]
14. Radiotelemetric monitoring of blood pressure and mesenteric arterial bed responsiveness in rats with streptozotocin-induced diabetes.
Tatchum-Talom R; Gopalakrishnan V; McNeill JR
Can J Physiol Pharmacol; 2000 Sep; 78(9):721-8. PubMed ID: 11007535
[TBL] [Abstract][Full Text] [Related]
15. Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition.
Nangle MR; Cotter MA; Cameron NE
Int J Impot Res; 2006; 18(3):258-63. PubMed ID: 16355109
[TBL] [Abstract][Full Text] [Related]
16. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin II on insulin receptor binding and mRNA levels in normal and diabetic rats.
Sechi LA; Griffin CA; Zingaro L; Valentin JP; Bartoli E; Schambelan M
Diabetologia; 1997 Jul; 40(7):770-7. PubMed ID: 9243097
[TBL] [Abstract][Full Text] [Related]
19. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
Anderson S; Chapman JG; Oyama TT; Komers R
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):19-23. PubMed ID: 19473197
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
